Skip to content

Effects of Mindfulness-Based Elder Care (MBEC) on symptoms of depression and anxiety and spiritual well-being of institutionalized seniors with disabilities: a randomized controlled trial

Yvonne Hsiung, Yi‐Heng Chen, Li-Chan Lin, Yu-Han Wang

BMC Geriatrics August 18, 2023 DOI: 10.1186/s12877-023-04220-6 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Peer reviewed
Sample size 77
Population Seniors with disabilities in long-term care residential settings
Intervention Mindfulness-based elder care (MBEC) program
Duration 8-week intervention, with assessments at baseline, mid-intervention (4 weeks), post-intervention (8 weeks), and follow-up
Measures Geriatric Depression Scale Short Form (GDS-SF), State-Trait Anxiety Inventory (STAI), Spiritual Well-Being Scale (SWBS)
Topics Anxiety Depression Meditation
Citations 15
Registration NCT05123261
Key findings The eight-week mindfulness-based elder care program significantly reduced state anxiety at post-intervention, trait anxiety at post-intervention and follow-up, and depressive symptoms, and significantly improved spiritual well-being compared with controls. The authors conclude the program has positive effects on mental health and spiritual well-being and recommend integrating it into long-term care routines.

Abstract

Abstract Background Despite the need to incorporate seniors from various settings into mindfulness-based empirical research, issues of geriatric frailties and non-compliance remain. This study aimed to evaluate the effects of a mindfulness-based elder care (MBEC) program on mental health and spiritual well-being among seniors with disabilities in long-term care residential settings.

Methods: This single-blind, randomized controlled trial (RCT) randomly assigned seventy-seven participants into an MBEC group or control group of an eight-week MBEC program. Participants were assessed every four weeks at baseline (T 0 ), mid-intervention (T 1 ), post-intervention (T 2 ) and follow-up (T 3 ) using the Geriatric Depression Scale Short Form (GDS-SF), the State-Trait Anxiety Inventory (STAI) and the Spiritual Well-Being Scale (SWBS), respectively.

Results: Linear mixed model (LMM) showed that MBEC participants’ mental health improved significantly after completing the intervention; compared with controls, the MBEC group exhibited significantly lower anxiety (state-anxiety at T 2 ; trait-anxiety at T 2 and T 3 ) and fewer depressive symptoms. Spiritual well-being was also significantly enhanced compared to that in the control group.

Conclusions: MBEC has positive effects on both mental health and spiritual well-being outcomes among seniors with disabilities. In long-term care facilities, seniors with abilities have the potential to adhere to and engage in activities of a mindfulness-based intervention. This low risk, easily accessible, and effective 8-week program is recommended to be integrated into regular long-term care institutional routines. Trial registration This study was registered with Clinical Trial Registry (ClinicalTrials.gov – U.S. National Library of Medicine #NCT05123261. Retrospectively registered on 07/04/2021.). The CONSORT 2010 guidelines were used in this study for properly reporting how the randomized trial was conducted.

Comparable studies

Other randomized controlled trials on anxiety, most cited first.

Study Year Design Participants
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Cancer patients with life-threatening diagnoses and symptoms of depression and/or anxiety 2016 Randomized controlled trial n = 51
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Patients with cancer-related anxiety and depression 2016 Double-blind, placebo-controlled, crossover trial n = 29
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Hallucinogen-naïve adults reporting regular participation in religious or spiritual... 2006 Double-blind study n = 36
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Adults with advanced-stage cancer and anxiety 2010 Double-blind, placebo-controlled study n = 12

Citations in the library

Cited by 4

Cites 9

and 4 more in the library

Explore topics